BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toledano-Fonseca M, Cano MT, Inga E, Gómez-España A, Guil-Luna S, García-Ortiz MV, Mena-Osuna R, De la Haba-Rodriguez JR, Rodríguez-Ariza A, Aranda E. The Combination of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer. Cancers (Basel) 2021;13:1210. [PMID: 33802006 DOI: 10.3390/cancers13061210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yildirim ÖA, Erdur E. Pancreatic cancer treatment after FOLFIRINOX: prognostic importance of chemotherapy dose intensity and albumin/globulin ratio in second line. Journal of Health Sciences and Medicine 2022;5:156-60. [DOI: 10.32322/jhsm.1011658] [Reference Citation Analysis]
2 Keup C, Kimmig R, Kasimir-bauer S. Combinatorial Power of cfDNA, CTCs and EVs in Oncology. Diagnostics 2022;12:870. [DOI: 10.3390/diagnostics12040870] [Reference Citation Analysis]
3 Jin L, Kim HS, Shi J. Neutrophil in the Pancreatic Tumor Microenvironment. Biomolecules 2021;11:1170. [PMID: 34439836 DOI: 10.3390/biom11081170] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]